Front Immunol:用细胞因子模式可以评价儿童噬血细胞性淋巴组织细胞增多症的临床状况和亚型

2022-03-22 从医路漫漫 MedSci原创

噬血细胞淋巴组织细胞增多症是一种危及生命的疾病,表现为严重的炎症反应引起的多器官功能障碍。过度激活的细胞毒性T细胞和巨噬细胞以及铺天盖地的细胞因子风暴导致了致命的结果。

背景:噬血细胞淋巴组织细胞增多症是一种危及生命的疾病,表现为严重的炎症反应引起的多器官功能障碍。过度激活的细胞毒性T细胞和巨噬细胞以及铺天盖地的细胞因子风暴导致了致命的结果。由于高细胞分裂素血症在HLH发病中起关键作用,我们自2005年起对儿童HLH患者进行了血清Th1/Th2细胞因子检测,并报告了IFN-γ和IL-10水平显著升高和IL-6水平轻微升高的细胞因子模式对儿童HLH的高度特异性。在儿科血液肿瘤科发热患者中,当IFN-γ>75pg/m l、IL-10>60pg/m l时,诊断HLH的灵敏度和特异度均高于90%。这种细胞因子模式已被推荐用于继发性HLH和感染的鉴别诊断。此外,细胞因子如IFN-γ和IL-10与器官损害的严重程度和预后密切相关,它们已被用作危险分层和治疗选择的重要生物标志物。然而,随着越来越多的人促黄体生成素的积累,我们发现并非所有的人促黄体生成素患者都呈现出上述细胞因子模式。例如,X连锁淋巴增生性疾病(XLP)和STAT1功能获得突变的患者表现出低水平的IL-10和IFN-γ。最近的一份报告还显示,由不同基础疾病引起的HLHS患者的IL-6、IL-10和IFN-γ水平也不同。因此,有必要澄清不同亚型的HLH是否呈现不同的细胞因子模式,以提高这项测试的诊断准确性。

   由于HLH进展迅速,为了挽救生命,早期开始治疗势在必行。当或甚至在HLH诊断作出之前,通常需要决定是否使用HLH-94方案的成分,包括依托泊苷。然而,由于不同亚型HLH的治疗策略不同,在潜在原因尚不确定的情况下,选择可行的治疗方案是临床医生面临的一大挑战。由于细胞因子的模式和水平可以提供快速(采血后<5小时)关于HLH诊断、严重程度甚至亚型的信息,当需要快速决定最初的HLH治疗时,它可能是一个有用的评估工具。

噬血细胞淋巴组织细胞增多症是一种由免疫失调引起的快速致死性疾病。为了挽救生命,必须尽早开始治疗。然而,目前尚缺乏一种可用于快速评估HLH亚型和临床情况的实验室方法。我们以前的研究表明,细胞因子如IFN-γ和IL-10有助于HLH的早期诊断,并与疾病的严重程度有关。本研究的目的是阐明不同亚型的细胞因子在儿童HLH型中的不同模式,并探讨细胞因子在简单评估疾病特征中的作用。

目的:在此,我们调查了2010年1月至2020年12月在我所初诊为HLH的儿科患者的临床资料,旨在探讨HLH不同亚型的细胞因子模式以及细胞因子在评估疾病特征中的作用。

患者和方法:我们招募了256名新诊断为HLH的儿科患者。收集临床表现和实验室检查结果,并比较不同亚型的HLH值。建立一个整合细胞因子的模型,将HLH患者分为不同的临床组。

结果:27例确诊为原发性HLH型,179例诊断为EBV-HLH型,50例为其他原因。IL-6、IL-10和IFN-γ水平及IL-10/IFN-γ比值在EBV-HLH、其他感染相关HLH、恶性肿瘤相关HLH、家族性HLH和X连锁淋巴增生性疾病之间存在差异。IL-10/IFN-γ比值>1.33,IFN-γ-≤浓度>225pg/ml者,其敏感性为73%,特异性为84%。建立了基于两个分界值的四象限模型,将患者分成不同的临床情况。四个象限的HLH亚型、细胞因子水平、治疗方案、治疗反应和预后不同,8周死亡率从2.9±2.9%降至21.4±5.5%,5年总生存率从93.9±4.2%降至52.6±7.1%。

图1 细胞因子水平和细胞因子模式。(A)HLH中IL-2、IL-4、IL-6、IL-10、肿瘤坏死因子-α和IFN-γ水平的盒和须图。每个细胞因子的中位数水平(线条)、第25到75%百分位数(框)和最小到最大值(胡须)都会显示出来。这些数字是每种细胞因子的中位数和范围。(B)基于IL-6、IL-10和IFN-γ的不同形式的HLH的不同细胞因子模式。每个细胞因子的中位数水平(线条)、第25至75个百分位数(方框)和第5至95个百分位数(胡须)都显示出来。(C)不同亚型HLH5年总生存期(OS)的Kaplan-Meier生存曲线。I-HLH,由EBV以外的病原体引发的感染相关HLH;M-HLH,恶性肿瘤相关HLH;FHL,家族性HLH;XLP,X连锁淋巴组织增生性疾病。

表1 不同形式的促黄体生成素的细胞因子水平和比率。

图2:原发性促黄体生成素与继发性促黄体生成素的区别。(A)用IL-10/干扰素-g比值预测PHLH的受试者工作特征(ROC)曲线。(B)用IFN-γ水平预测sHLH的ROC曲线。

表2 在四象限模型中位于不同象限的HLH患者的临床特征。

结论:不同亚型的HLH表现出不同的细胞因子模式。IFN-γ和IL-10/IFN-γ比值是鉴别HLH亚型的有用指标。基于这两个参数的四象限模型是一种简单评估HLH情况的有用工具。

原文出处:Xu XJ,  Luo ZB,  Song H, et al.Simple Evaluation of Clinical Situation and Subtypes of Pediatric Hemophagocytic Lymphohistiocytosis by Cytokine Patterns.Front Immunol 2022;13

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1809657, encodeId=38db180965ed1, content=<a href='/topic/show?id=6cd683e603b' target=_blank style='color:#2F92EE;'>#胞因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83760, encryptionId=6cd683e603b, topicName=胞因子)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Mon Nov 28 09:37:14 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805213, encodeId=80611805213c2, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77906, encryptionId=3138e790655, topicName=细胞性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86b7385, createdName=lqrandywkz, createdTime=Sun Jan 22 11:37:14 CST 2023, time=2023-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681892, encodeId=5d4d16818925b, content=<a href='/topic/show?id=2fb489882cb' target=_blank style='color:#2F92EE;'>#血细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89882, encryptionId=2fb489882cb, topicName=血细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a79127868468, createdName=ailian1211, createdTime=Thu Feb 02 05:37:14 CST 2023, time=2023-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218080, encodeId=cc241218080b3, content=<a href='/topic/show?id=2f16e785571' target=_blank style='color:#2F92EE;'>#细胞因子风暴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77855, encryptionId=2f16e785571, topicName=细胞因子风暴)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 11:17:56 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741244, encodeId=472e1e4124452, content=<a href='/topic/show?id=ed5340355da' target=_blank style='color:#2F92EE;'>#噬血细胞性淋巴组织细胞增多症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40355, encryptionId=ed5340355da, topicName=噬血细胞性淋巴组织细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f434894762, createdName=12498e8em83暂无昵称, createdTime=Mon Apr 25 22:37:14 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1283691, encodeId=ea471283691ee, content=<a href='/topic/show?id=2c00e784416' target=_blank style='color:#2F92EE;'>#细胞因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77844, encryptionId=2c00e784416, topicName=细胞因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Thu Mar 24 13:37:14 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444765, encodeId=893a1444e65ba, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Mar 24 13:37:14 CST 2022, time=2022-03-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1809657, encodeId=38db180965ed1, content=<a href='/topic/show?id=6cd683e603b' target=_blank style='color:#2F92EE;'>#胞因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83760, encryptionId=6cd683e603b, topicName=胞因子)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Mon Nov 28 09:37:14 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805213, encodeId=80611805213c2, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77906, encryptionId=3138e790655, topicName=细胞性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86b7385, createdName=lqrandywkz, createdTime=Sun Jan 22 11:37:14 CST 2023, time=2023-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681892, encodeId=5d4d16818925b, content=<a href='/topic/show?id=2fb489882cb' target=_blank style='color:#2F92EE;'>#血细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89882, encryptionId=2fb489882cb, topicName=血细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a79127868468, createdName=ailian1211, createdTime=Thu Feb 02 05:37:14 CST 2023, time=2023-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218080, encodeId=cc241218080b3, content=<a href='/topic/show?id=2f16e785571' target=_blank style='color:#2F92EE;'>#细胞因子风暴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77855, encryptionId=2f16e785571, topicName=细胞因子风暴)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 11:17:56 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741244, encodeId=472e1e4124452, content=<a href='/topic/show?id=ed5340355da' target=_blank style='color:#2F92EE;'>#噬血细胞性淋巴组织细胞增多症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40355, encryptionId=ed5340355da, topicName=噬血细胞性淋巴组织细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f434894762, createdName=12498e8em83暂无昵称, createdTime=Mon Apr 25 22:37:14 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1283691, encodeId=ea471283691ee, content=<a href='/topic/show?id=2c00e784416' target=_blank style='color:#2F92EE;'>#细胞因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77844, encryptionId=2c00e784416, topicName=细胞因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Thu Mar 24 13:37:14 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444765, encodeId=893a1444e65ba, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Mar 24 13:37:14 CST 2022, time=2022-03-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1809657, encodeId=38db180965ed1, content=<a href='/topic/show?id=6cd683e603b' target=_blank style='color:#2F92EE;'>#胞因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83760, encryptionId=6cd683e603b, topicName=胞因子)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Mon Nov 28 09:37:14 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805213, encodeId=80611805213c2, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77906, encryptionId=3138e790655, topicName=细胞性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86b7385, createdName=lqrandywkz, createdTime=Sun Jan 22 11:37:14 CST 2023, time=2023-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681892, encodeId=5d4d16818925b, content=<a href='/topic/show?id=2fb489882cb' target=_blank style='color:#2F92EE;'>#血细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89882, encryptionId=2fb489882cb, topicName=血细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a79127868468, createdName=ailian1211, createdTime=Thu Feb 02 05:37:14 CST 2023, time=2023-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218080, encodeId=cc241218080b3, content=<a href='/topic/show?id=2f16e785571' target=_blank style='color:#2F92EE;'>#细胞因子风暴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77855, encryptionId=2f16e785571, topicName=细胞因子风暴)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 11:17:56 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741244, encodeId=472e1e4124452, content=<a href='/topic/show?id=ed5340355da' target=_blank style='color:#2F92EE;'>#噬血细胞性淋巴组织细胞增多症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40355, encryptionId=ed5340355da, topicName=噬血细胞性淋巴组织细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f434894762, createdName=12498e8em83暂无昵称, createdTime=Mon Apr 25 22:37:14 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1283691, encodeId=ea471283691ee, content=<a href='/topic/show?id=2c00e784416' target=_blank style='color:#2F92EE;'>#细胞因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77844, encryptionId=2c00e784416, topicName=细胞因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Thu Mar 24 13:37:14 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444765, encodeId=893a1444e65ba, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Mar 24 13:37:14 CST 2022, time=2022-03-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1809657, encodeId=38db180965ed1, content=<a href='/topic/show?id=6cd683e603b' target=_blank style='color:#2F92EE;'>#胞因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83760, encryptionId=6cd683e603b, topicName=胞因子)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Mon Nov 28 09:37:14 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805213, encodeId=80611805213c2, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77906, encryptionId=3138e790655, topicName=细胞性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86b7385, createdName=lqrandywkz, createdTime=Sun Jan 22 11:37:14 CST 2023, time=2023-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681892, encodeId=5d4d16818925b, content=<a href='/topic/show?id=2fb489882cb' target=_blank style='color:#2F92EE;'>#血细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89882, encryptionId=2fb489882cb, topicName=血细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a79127868468, createdName=ailian1211, createdTime=Thu Feb 02 05:37:14 CST 2023, time=2023-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218080, encodeId=cc241218080b3, content=<a href='/topic/show?id=2f16e785571' target=_blank style='color:#2F92EE;'>#细胞因子风暴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77855, encryptionId=2f16e785571, topicName=细胞因子风暴)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 11:17:56 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741244, encodeId=472e1e4124452, content=<a href='/topic/show?id=ed5340355da' target=_blank style='color:#2F92EE;'>#噬血细胞性淋巴组织细胞增多症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40355, encryptionId=ed5340355da, topicName=噬血细胞性淋巴组织细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f434894762, createdName=12498e8em83暂无昵称, createdTime=Mon Apr 25 22:37:14 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1283691, encodeId=ea471283691ee, content=<a href='/topic/show?id=2c00e784416' target=_blank style='color:#2F92EE;'>#细胞因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77844, encryptionId=2c00e784416, topicName=细胞因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Thu Mar 24 13:37:14 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444765, encodeId=893a1444e65ba, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Mar 24 13:37:14 CST 2022, time=2022-03-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1809657, encodeId=38db180965ed1, content=<a href='/topic/show?id=6cd683e603b' target=_blank style='color:#2F92EE;'>#胞因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83760, encryptionId=6cd683e603b, topicName=胞因子)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Mon Nov 28 09:37:14 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805213, encodeId=80611805213c2, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77906, encryptionId=3138e790655, topicName=细胞性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86b7385, createdName=lqrandywkz, createdTime=Sun Jan 22 11:37:14 CST 2023, time=2023-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681892, encodeId=5d4d16818925b, content=<a href='/topic/show?id=2fb489882cb' target=_blank style='color:#2F92EE;'>#血细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89882, encryptionId=2fb489882cb, topicName=血细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a79127868468, createdName=ailian1211, createdTime=Thu Feb 02 05:37:14 CST 2023, time=2023-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218080, encodeId=cc241218080b3, content=<a href='/topic/show?id=2f16e785571' target=_blank style='color:#2F92EE;'>#细胞因子风暴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77855, encryptionId=2f16e785571, topicName=细胞因子风暴)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 11:17:56 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741244, encodeId=472e1e4124452, content=<a href='/topic/show?id=ed5340355da' target=_blank style='color:#2F92EE;'>#噬血细胞性淋巴组织细胞增多症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40355, encryptionId=ed5340355da, topicName=噬血细胞性淋巴组织细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f434894762, createdName=12498e8em83暂无昵称, createdTime=Mon Apr 25 22:37:14 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1283691, encodeId=ea471283691ee, content=<a href='/topic/show?id=2c00e784416' target=_blank style='color:#2F92EE;'>#细胞因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77844, encryptionId=2c00e784416, topicName=细胞因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Thu Mar 24 13:37:14 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444765, encodeId=893a1444e65ba, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Mar 24 13:37:14 CST 2022, time=2022-03-24, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1809657, encodeId=38db180965ed1, content=<a href='/topic/show?id=6cd683e603b' target=_blank style='color:#2F92EE;'>#胞因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83760, encryptionId=6cd683e603b, topicName=胞因子)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Mon Nov 28 09:37:14 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805213, encodeId=80611805213c2, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77906, encryptionId=3138e790655, topicName=细胞性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86b7385, createdName=lqrandywkz, createdTime=Sun Jan 22 11:37:14 CST 2023, time=2023-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681892, encodeId=5d4d16818925b, content=<a href='/topic/show?id=2fb489882cb' target=_blank style='color:#2F92EE;'>#血细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89882, encryptionId=2fb489882cb, topicName=血细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a79127868468, createdName=ailian1211, createdTime=Thu Feb 02 05:37:14 CST 2023, time=2023-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218080, encodeId=cc241218080b3, content=<a href='/topic/show?id=2f16e785571' target=_blank style='color:#2F92EE;'>#细胞因子风暴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77855, encryptionId=2f16e785571, topicName=细胞因子风暴)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 11:17:56 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741244, encodeId=472e1e4124452, content=<a href='/topic/show?id=ed5340355da' target=_blank style='color:#2F92EE;'>#噬血细胞性淋巴组织细胞增多症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40355, encryptionId=ed5340355da, topicName=噬血细胞性淋巴组织细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f434894762, createdName=12498e8em83暂无昵称, createdTime=Mon Apr 25 22:37:14 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1283691, encodeId=ea471283691ee, content=<a href='/topic/show?id=2c00e784416' target=_blank style='color:#2F92EE;'>#细胞因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77844, encryptionId=2c00e784416, topicName=细胞因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Thu Mar 24 13:37:14 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444765, encodeId=893a1444e65ba, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Mar 24 13:37:14 CST 2022, time=2022-03-24, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1809657, encodeId=38db180965ed1, content=<a href='/topic/show?id=6cd683e603b' target=_blank style='color:#2F92EE;'>#胞因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83760, encryptionId=6cd683e603b, topicName=胞因子)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/017ED6AFEB45F49165298113DDC0656A/100, createdBy=84182500174, createdName=ms7019579240139182, createdTime=Mon Nov 28 09:37:14 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805213, encodeId=80611805213c2, content=<a href='/topic/show?id=3138e790655' target=_blank style='color:#2F92EE;'>#细胞性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77906, encryptionId=3138e790655, topicName=细胞性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86b7385, createdName=lqrandywkz, createdTime=Sun Jan 22 11:37:14 CST 2023, time=2023-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681892, encodeId=5d4d16818925b, content=<a href='/topic/show?id=2fb489882cb' target=_blank style='color:#2F92EE;'>#血细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89882, encryptionId=2fb489882cb, topicName=血细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a79127868468, createdName=ailian1211, createdTime=Thu Feb 02 05:37:14 CST 2023, time=2023-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218080, encodeId=cc241218080b3, content=<a href='/topic/show?id=2f16e785571' target=_blank style='color:#2F92EE;'>#细胞因子风暴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77855, encryptionId=2f16e785571, topicName=细胞因子风暴)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 11:17:56 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741244, encodeId=472e1e4124452, content=<a href='/topic/show?id=ed5340355da' target=_blank style='color:#2F92EE;'>#噬血细胞性淋巴组织细胞增多症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40355, encryptionId=ed5340355da, topicName=噬血细胞性淋巴组织细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f434894762, createdName=12498e8em83暂无昵称, createdTime=Mon Apr 25 22:37:14 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1283691, encodeId=ea471283691ee, content=<a href='/topic/show?id=2c00e784416' target=_blank style='color:#2F92EE;'>#细胞因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77844, encryptionId=2c00e784416, topicName=细胞因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Thu Mar 24 13:37:14 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444765, encodeId=893a1444e65ba, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Thu Mar 24 13:37:14 CST 2022, time=2022-03-24, status=1, ipAttribution=)]

相关资讯

​糖尿病治疗新突破!人工胰腺可显著改善儿童血糖水平

1型糖尿病多发于儿童和青少年,疾病的日常监控面临挑战。

Pediatrics:儿童探视中常规体温测量的频率和结果

健康儿童就诊是儿童接受非卧床看护的最常见原因。美国儿科学会预防护理指南“光明未来”就健康监督、预见性指导、疾病和发育筛查提供建议,对从出生到青春期的健康儿童就诊。

Stroke:急性缺血性卒中儿童血管内血栓切除术的疗效

对接受EVT治疗的缺血性卒中儿科患者的临床病程和短期结局的横断面评估表明,EVT可能是一种安全的方式,可获得较高的良好功能结局。

JAHA:感染新冠肺炎的儿童,3个月内可完全恢复正常的心脏功能

一项发表在JAHA杂志上的研究显示,患有与新型冠状病毒肺炎(COVID-19)相关的多系统炎症综合征(MIS-C)的儿童,在出院后的第一周开始康复,并在3个月内完全恢复正常的心脏功能。

Eur Arch Otorhinolaryngol:感音神经性听力损失儿童中,前庭异常反应的发生率如何?

利用vHIT、cVEMP和oVEMP检测来确定SNHL患儿前庭反应异常的发生率。

JAMA Otolaryngol Head Neck Surg:城市低收入公立幼儿园中,儿童早期听力筛查计划的结果如何?

评估了低收入家庭学龄前儿童听力筛查项目的结果以及这一人群的听力损失的风险因素。